Medicine
Furosemide 40 mg tablet
Furosemide 40 mg tablet is a generic prescription medicine for oral use, made by 28 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° -25° C (68° -77° F). Protect from light.
Key facts
- Active ingredient (INN)
- Furosemide
- Brand
- Sold under the generic name
- Strength
- 40 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 1000 tablets, 10 tablets and 138 more
- Manufacturers
- Ipca LaboratoriesIndiaAurobindo PharmaIndiaA-S Medication SolutionsSolco HealthcareGranulation TechnologyHikma PharmaceuticalsLeading PharmaRising Pharma HoldingsCalvin ScottChartwell RX28 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° -25° C (68° -77° F). Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C03CA01 Furosemide
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 10 November 1983
- Identifiers
- RxCUI 313988, 197732, 310429 +2DailyMed set ID 3f6529fb-1173-ada3-e063-6294a90a76cb, 020bc039-9e99-4895-96f8-0c6a556d3e67, b2cc89e5-6619-4113-ad31-48076652c856 +37NDC 71610-951, 72162-1361, 17224-185 +37Application ANDA077293, ANDA076796, ANDA216629 +5
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 28 labelers. The register lists 141 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 59651-797-01 | Aurobindo PharmaIndia | 17 July 2025 |
| 1000 tablet in 1 bottle | 59651-797-99 | Aurobindo PharmaIndia | 17 July 2025 |
| 100 tablet in 1 bottle | 83980-003-01 | Ipca LaboratoriesIndia | 3 June 2024 |
| 1000 tablet in 1 bottle | 83980-003-10 | Ipca LaboratoriesIndia | 3 June 2024 |
| 10 tablet in 1 bottle | 83980-003-97 | Ipca LaboratoriesIndia | 3 June 2024 |
| 100 tablet in 1 bottle | 0054-4299-25 | Hikma Pharmaceuticals | 10 November 1983 |
| 1000 tablet in 1 bottle | 0054-4299-31 | Hikma Pharmaceuticals | 10 November 1983 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 0054-8299-25 | Hikma Pharmaceuticals | 10 November 1983 |
| 21 tablet in 1 bottle, plastic | 17224-185-21 | Calvin Scott | 15 May 2016 |
| 90 tablet in 1 package | 62135-754-90 | Chartwell RX | 17 April 2024 |
| 100 tablet in 1 bottle | 63561-0165-1 | Granulation Technology | 15 January 2026 |
| 1000 tablet in 1 bottle | 63561-0165-2 | Granulation Technology | 18 December 2025 |
| 90 tablet in 1 bottle | 63561-0165-9 | Granulation Technology | 18 December 2025 |
| 100 tablet in 1 bottle | 69315-117-01 | Leading Pharma | 15 May 2016 |
| 1000 tablet in 1 bottle | 69315-117-10 | Leading Pharma | 15 May 2016 |
| 100 tablet in 1 bottle | 64980-563-01 | Rising Pharma Holdings | 5 November 2022 |
| 1000 tablet in 1 bottle | 64980-563-10 | Rising Pharma Holdings | 5 November 2022 |
| 100 tablet in 1 bottle, plastic | 43547-402-10 | Solco Healthcare | 26 March 2004 |
| 1000 tablet in 1 bottle, plastic | 43547-402-11 | Solco Healthcare | 26 March 2004 |
| 5000 tablet in 1 bottle, plastic | 43547-402-51 | Solco Healthcare | 26 March 2004 |
| 1000000 tablet in 1 drum | 43547-402-94 | Solco Healthcare | 1 January 2022 |
| 30 tablet in 1 bottle | 50090-3313-0 | A-S Medication Solutions | 23 September 2021 |
| 100 tablet in 1 bottle | 50090-3313-1 | A-S Medication Solutions | 2 January 2018 |
| 60 tablet in 1 bottle | 50090-3313-3 | A-S Medication Solutions | 12 January 2022 |
| 90 tablet in 1 bottle | 50090-3313-9 | A-S Medication Solutions | 27 December 2017 |
| 100 tablet in 1 bottle | 50090-5702-0 | A-S Medication Solutions | 23 September 2021 |
| 180 tablet in 1 bottle | 50090-5702-1 | A-S Medication Solutions | 18 April 2023 |
| 30 tablet in 1 bottle | 50090-6646-0 | A-S Medication Solutions | 29 August 2023 |
| 100 tablet in 1 bottle | 50090-6646-1 | A-S Medication Solutions | 29 August 2023 |
| 60 tablet in 1 bottle | 50090-6646-3 | A-S Medication Solutions | 29 August 2023 |
| 90 tablet in 1 bottle | 50090-6646-9 | A-S Medication Solutions | 29 August 2023 |
| 180 tablet in 1 bottle | 50090-6647-1 | A-S Medication Solutions | 29 August 2023 |
| 90 tablet in 1 bottle | 50090-6937-0 | A-S Medication Solutions | 15 December 2023 |
| 30 tablet in 1 bottle | 50090-7703-0 | A-S Medication Solutions | 14 October 2025 |
| 100 tablet in 1 bottle | 50090-7703-1 | A-S Medication Solutions | 14 October 2025 |
| 60 tablet in 1 bottle | 50090-7703-3 | A-S Medication Solutions | 14 October 2025 |
| 90 tablet in 1 bottle | 50090-7703-9 | A-S Medication Solutions | 14 October 2025 |
| 180 tablet in 1 bottle | 50090-7704-1 | A-S Medication Solutions | 14 October 2025 |
| 90 tablet in 1 bottle | 50090-7705-0 | A-S Medication Solutions | 14 October 2025 |
| 100 tablet in 1 bottle | 68071-1809-1 | NuCare Pharmaceuticals,Inc | 29 January 2019 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Furosemide 40 mg tablet.
Other strengths and forms of Furosemide
Clinical summary
Furosemide is a loop diuretic indicated in adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. MedsAcross supplies Furosemide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about FurosemideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Lasix prescribing information (Validus Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Bopediat: European public assessment report (EPAR) · European Medicines Agency
Need Furosemide 40 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.